2m 2m 2m 2m 2m 2m 2m
Intuitive Surgic (ISRG)
NASDAQ
$403.95+$1.00 (+0.25%)
Price as of Jun 23, 2026 5:31 PM EDT- $142.7BMarket Cap
- -21.77%1-Year Change
- Medical Instruments & SuppliesIndustry
Intuitive Surgic (ISRG)
$403.95+$1.00 (+0.25%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD GROUP INC | 9.49% | 33.6M | +13,637 (+0.04%) | Dec 31, 2025 |
BLACKROCK FUNDING, INC. /DE | 8.86% | 31.4M | +1.2M (+3.78%) | Dec 31, 2024 |
BLACKROCK INC. | 8.51% | 30.1M | -199,397 (-0.66%) | Jun 30, 2024 |
BLACKROCK, INC. | 8.49% | 30.1M | -440,248 (-1.46%) | Mar 31, 2026 |
N/A | 6.52% | 23.1M | +23.1M (+100.00%) | Mar 31, 2026 |
STATE STREET CORP | 4.47% | 15.8M | +145,382 (+0.92%) | Mar 31, 2026 |
PRICE T ROWE ASSOCIATES INC /MD/ | 3.54% | 12.5M | -34,756 (-0.28%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 6.94% | 24.6M | +253,158 (+1.03%) | Mar 31, 2026 |
iSHARES TRUST | 2.68% | 9.5M | -280,796 (-2.96%) | Mar 31, 2026 |
INVESCO QQQ TRUST, SERIES 1 | 2.11% | 7.5M | -473,092 (-6.32%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 1.68% | 6.0M | -14 (-0.0002%) | Feb 28, 2026 |
SPDR S&P 500 ETF TRUST | 1.17% | 4.1M | -183,597 (-4.44%) | Mar 31, 2026 |
GROWTH FUND OF AMERICA | 0.76% | 2.7M | 0 (0.00%) | Feb 28, 2026 |
SELECT SECTOR SPDR TRUST | 0.73% | 2.6M | +78,639 (+3.04%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions5.3B (81.95%)
- Mutual Funds1.2B (18.02%)
- Insiders1.6M (0.03%)
- Other0 (0.00%)
Insider Transactions
- 0.03% (1.6M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 9Number of InsiderSelling (last 12 months)
- $190.6MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Brosius Mark EVP & Chief Mfg and Supply Cha | Sell | Jun 12, 2026 | $10,353.25 | 25 | $414.13 | 1,406 |
Brosius Mark EVP & Chief Mfg and Supply Cha | Sell | Jun 11, 2026 | $9,479.68 | 23 | $412.16 | 1,431 |
Brosius Mark EVP & Chief Mfg and Supply Cha | Sell | Jun 10, 2026 | $9,755.22 | 23 | $424.14 | 1,454 |
Rosa David J. Chief Executive Officer (CEO) | Exempt | Jun 10, 2026 | $0.00 | 1,358 | $0.00 | 1,358 |
LOEB GARY EVP & Chief Legal and Complian | Sell | Jun 10, 2026 | $169,656.00 | 400 | $424.14 | 5,720 |
Rosa David J. Chief Executive Officer (CEO) | Exempt | Jun 10, 2026 | $0.00 | 1,358 | $0.00 | 246,567 |
Rosa David J. Chief Executive Officer (CEO) | In Kind | Jun 10, 2026 | $287,535.14 | 674 | $426.61 | 245,893 |
Brosius Mark EVP & Chief Mfg and Supply Cha | Sell | Jun 09, 2026 | $9,685.99 | 23 | $421.13 | 1,477 |
Brosius Mark EVP & Chief Mfg and Supply Cha | Sell | Jun 08, 2026 | $9,662.76 | 23 | $420.12 | 1,500 |
Myriam Curet EVP & Chief Medical Officer | Exempt | Mar 10, 2026 | $0.00 | 105 | $0.00 | 1,152 |
Myriam Curet EVP & Chief Medical Officer | Exempt | Mar 10, 2026 | $24,085.95 | 105 | $229.39 | 105 |
Myriam Curet EVP & Chief Medical Officer | Sell | Mar 10, 2026 | $51,864.75 | 105 | $493.95 | 0 |
Brosius Mark SVP & Chief Mfg and Supply Cha | Sell | Mar 09, 2026 | $312,831.45 | 645 | $485.01 | 1,613 |
Brosius Mark SVP & Chief Mfg and Supply Cha | Sell | Mar 06, 2026 | $317,643.12 | 648 | $490.19 | 2,258 |
Brosius Mark SVP & Chief Mfg and Supply Cha | Sell | Mar 05, 2026 | $320,889.60 | 648 | $495.20 | 2,906 |
Brosius Mark SVP & Chief Mfg and Supply Cha | Sell | Mar 04, 2026 | $1.2M | 2,362 | $498.68 | 3,554 |
Widman Fredrik VP Corporate Controller | Sell | Mar 03, 2026 | $57,487.24 | 118 | $487.18 | 1,026 |
Myriam Curet EVP & Chief Medical Officer | Sell | Mar 03, 2026 | $2.3M | 4,728 | $487.18 | 409 |
Brosius Mark SVP & Chief Mfg and Supply Cha | Sell | Mar 03, 2026 | $316,288.80 | 648 | $488.10 | 5,916 |
Myriam Curet EVP & Chief Medical Officer | Exempt | Mar 02, 2026 | $0.00 | 125 | $0.00 | 0 |
Myriam Curet EVP & Chief Medical Officer | Exempt | Mar 02, 2026 | $26,112.50 | 125 | $208.90 | 5,262 |
Myriam Curet EVP & Chief Medical Officer | Sell | Mar 02, 2026 | $61,573.75 | 125 | $492.59 | 5,137 |
Jeddi Iman SVP & GM da Vinci Platforms & | Exempt | Feb 28, 2026 | $0.00 | 8,378 | $0.00 | 0 |
Rosa David J. Chief Executive Officer (CEO) | Exempt | Feb 28, 2026 | $0.00 | 14,363 | $0.00 | 0 |
GUTHART GARY S | Exempt | Feb 28, 2026 | $0.00 | 26,334 | $0.00 | 0 |
Charlton Henry L EVP & Chief Commercial and Mkt | Exempt | Feb 28, 2026 | $0.00 | 10,773 | $0.00 | 0 |
Brosius Mark SVP & Chief Mfg and Supply Cha | Exempt | Feb 28, 2026 | $0.00 | 8,378 | $0.00 | 0 |
Rosa David J. Chief Executive Officer (CEO) | Exempt | Feb 28, 2026 | $0.00 | 9,052 | $0.00 | 0 |
Myriam Curet EVP & Chief Medical Officer | Exempt | Feb 28, 2026 | $0.00 | 1,002 | $0.00 | 1,411 |
Charlton Henry L EVP & Chief Commercial and Mkt | Exempt | Feb 28, 2026 | $0.00 | 752 | $0.00 | 0 |